Abstract
Less than a half of hepatitis C patients respond to the current therapy by peg-interferon combined with ribavirin, and the genomic basis of those drug resistance remains unknown. It is recognized that the emerging challenge in the development of therapies for hepatitis C is new functions and mysteries of hepatitis C virus (HCV) non structural 5A (NS5A) protein. Different from current studies using small experimental samples to analyze relations between the HCV NS5A region and the response to interferon/ribavirin therapy, we introduce a data mining-based framework that exploits the largest available HCV database. This paper focuses on the methodology and early results of analyzing NS5A data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Murray, P.R., Rosenthal, K.S., Pfaller, M.A.: Medical Microbiology, Ch. 66. Mosby Philadelphia (2009)
Gao, M., Nettles, R.E., et al.: Chemical genetics strategy identifies an hcv ns5a inhibitor with a potent clinical effect. Nature 465, 953–960 (2010)
Lemon, S.M., Keating, J.A., Pietschmannc, T., Frickd, D.N., Glenne, J.S., Tellinghuisenf, T.L., Symonsg, J., Furman, P.A.: Development of novel therapies for hepatitis c. Antiviral Research 86, 79–92 (2010)
Jardim, A.C.G., Yamasaki, L.H.T., Queiro, A.T.L., Bittar, C., Rahal, R.P.R., de Carvalho Mello, I.M.V.: Quasispecies of hepatitis c virus genotype 1 and treatment outcome with peginterferon and ribavirin. Infection, Genetics and Evolution 9, 689–698 (2009)
Aurora, R., Donlin, M.J., Cannon, N.A.: Genome-wide hepatitis c virus amino acid covariance networks can predict response to antiviral therapy in humans. The Journal of Clinical Investigation 119, 225–236 (2009)
Feld, J.J., Hoofnagle, J.H.: Mechanism of action of interferon and ribavirin in treatment of hepatitis c. Nature 436, 967–972 (2005)
Enomoto, N., Maekawa, S.: Hcv genetic elements determining the early response to peginterferon and ribavirin therapy. Intervirology 334, 77–81 (2010)
Francessco, R., Migliaccio, G.: Challenges and successes in developing new therapies for hepatitis c. Nature 436, 96–100 (2005)
Guillou-Guillemette, H.L., Vallet, S., Gaudy-Graffin, C., Payan, C., Pivert, A., Goudeau, A., Lunel-Fabiani, F.: Genetic diversity of the hepatitis c virus: Impact and issues in the antiviral therapy. World Journal of Gastroenterology 13(17), 2416–2426 (2007)
AlHefnawi, M.M., Zada, S., El-Azab, I.A.: Prediction of prognostic biomarker for interferon-based therapy to hepatitis c virus patients: a metaanalysis of the ns5a protein in subtypes 1a, 1b, and 3a. Virology Journal 7, 1–9 (2010)
Macdonaldt, A., Harris, M.: Hepatitis c virus ns5a: Tales of a promiscuous protein. Journal of General Virology 85, 2485–2502 (2004)
Wohnsland, A., Hofmann, W.P., Sarrazin, C.: Viral determinants of resistance to treatment in patients with hepatitis c. Clinical Microbiology Reviews, 20 (2007)
Sharma, S.D.: Hepatitis c virus: Molecular biology & current therapetic options. Indian Journal of Medical Research 131, 17–34 (2010)
Kamal, S.M.: Acute hepatitis c: a systematic review. The American Journal of Gastroenterology 103(5), 1283–1297 (2008)
Kuiken, C., Yusim, K., Boykin, L., Richardson, R.: The los alamos hepatitis c sequence database. Bioinformatics 21(3), 379–384 (2005)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kawasaki, S., Ho, T.B., Kanda, T., Yokosuka, O., Takabayashi, K., Le, N. (2011). Discovering Relationship between Hepatitis C Virus NS5A Protein and Interferon/Ribavirin Therapy. In: Theeramunkong, T., Kunifuji, S., Sornlertlamvanich, V., Nattee, C. (eds) Knowledge, Information, and Creativity Support Systems. Lecture Notes in Computer Science(), vol 6746. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24788-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-24788-0_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24787-3
Online ISBN: 978-3-642-24788-0
eBook Packages: Computer ScienceComputer Science (R0)